Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study

BACKGROUND AND OBJECTIVE: Retrospective claims data in patients with chronic obstructive pulmonary disease (COPD) initiating maintenance therapy with inhaled fixed-dose combinations of long-acting muscarinic antagonist/long-acting β(2)-agonist (LAMA/LABA) versus inhaled corticosteroid (ICS)/LABA hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Moretz, Chad, Sharpsten, Lucie, Bengtson, Lindsay GS, Koep, Eleena, Le, Lisa, Tong, Junliang, Stanford, Richard H, Hahn, Beth, Ray, Riju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681903/
https://www.ncbi.nlm.nih.gov/pubmed/31534326
http://dx.doi.org/10.2147/COPD.S204649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681903/
https://www.ncbi.nlm.nih.gov/pubmed/31534326
http://dx.doi.org/10.2147/COPD.S204649

Ejemplares similares